Svensson, Magnus <br/><br/>
Better response with conjugate vaccine than with polysaccaride vaccine 12 months after rituximab treatment in lymphoma patients.  [electronic resource] 

 -  British journal of haematology  Feb 2012 
 - 407-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Letter; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2011.08867.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Bacterial--biosynthesis<br/>Antibodies, Monoclonal, Murine-Derived--pharmacology<br/>Antibody Formation--drug effects<br/>Antineoplastic Agents--pharmacology<br/>Bacterial Capsules--immunology<br/>Combined Modality Therapy<br/>Female<br/>Haemophilus Vaccines--immunology<br/>Haemophilus influenzae--immunology<br/>Humans<br/>Lymphoma, B-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Pneumococcal Vaccines--immunology<br/>Polysaccharides, Bacterial<br/>Rituximab<br/>Streptococcus pneumoniae--immunology<br/>Time Factors<br/>Vaccination<br/>Vaccines, Conjugate--immunology